New Article Details $93.3 Billion Annual Costs in Drug Utilization Management

An article published in Health Affairs details the multibillion-dollar costs associated with inflated drug utilization management. The estimated $93.3 billion spent each year impact payers, manufacturers, physicians, and patients.

“All stakeholders in the US pharmaceutical system would benefit from a deescalation of utilization management, combining lower drug prices with lower barriers to patient access.” Read more here.

(Source: Howell et al., Research Affairs, 8/2021)